Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome

Gordana Raca, Becky S. Baas, Salman Kirmani, Jennifer J. Laffin, Craig A. Jackson, Edythe A. Strand, Kathy J. Jakielski, Lawrence D. Shriberg

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

We report clinical findings that extend the phenotype of the ∼550 kb 16p11.2 microdeletion syndrome to include a rare, severe, and persistent pediatric speech sound disorder termed Childhood Apraxia of Speech (CAS). CAS is the speech disorder identified in a multigenerational pedigree ('KE') in which half of the members have a mutation in FOXP2 that co-segregates with CAS, oromotor apraxia, and low scores on a nonword repetition task. Each of the two patients in the current report completed a 2-h assessment protocol that provided information on their cognitive, language, speech, oral mechanism, motor, and developmental histories and performance. Their histories and standard scores on perceptual and acoustic speech tasks met clinical and research criteria for CAS. Array comparative genomic hybridization analyses identified deletions at chromosome 16p11.2 in each patient. These are the first reported cases with well-characterized CAS in the 16p11.2 syndrome literature and the first report of this microdeletion in CAS genetics research. We discuss implications of findings for issues in both literatures.

Original languageEnglish (US)
Pages (from-to)455-459
Number of pages5
JournalEuropean Journal of Human Genetics
Volume21
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Apraxias
Speech Acoustics
Speech Disorders
Chromosome Deletion
Genetic Research
Comparative Genomic Hybridization
Pedigree
Language
Pediatrics
Phenotype
Mutation
Research

Keywords

  • aCGH
  • apraxia
  • dyspraxia
  • FOXP2
  • speech sound disorder

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Raca, G., Baas, B. S., Kirmani, S., Laffin, J. J., Jackson, C. A., Strand, E. A., ... Shriberg, L. D. (2013). Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome. European Journal of Human Genetics, 21(4), 455-459. https://doi.org/10.1038/ejhg.2012.165

Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome. / Raca, Gordana; Baas, Becky S.; Kirmani, Salman; Laffin, Jennifer J.; Jackson, Craig A.; Strand, Edythe A.; Jakielski, Kathy J.; Shriberg, Lawrence D.

In: European Journal of Human Genetics, Vol. 21, No. 4, 04.2013, p. 455-459.

Research output: Contribution to journalArticle

Raca, G, Baas, BS, Kirmani, S, Laffin, JJ, Jackson, CA, Strand, EA, Jakielski, KJ & Shriberg, LD 2013, 'Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome', European Journal of Human Genetics, vol. 21, no. 4, pp. 455-459. https://doi.org/10.1038/ejhg.2012.165
Raca, Gordana ; Baas, Becky S. ; Kirmani, Salman ; Laffin, Jennifer J. ; Jackson, Craig A. ; Strand, Edythe A. ; Jakielski, Kathy J. ; Shriberg, Lawrence D. / Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome. In: European Journal of Human Genetics. 2013 ; Vol. 21, No. 4. pp. 455-459.
@article{a6c132181d554bb790eaa90c72b17963,
title = "Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome",
abstract = "We report clinical findings that extend the phenotype of the ∼550 kb 16p11.2 microdeletion syndrome to include a rare, severe, and persistent pediatric speech sound disorder termed Childhood Apraxia of Speech (CAS). CAS is the speech disorder identified in a multigenerational pedigree ('KE') in which half of the members have a mutation in FOXP2 that co-segregates with CAS, oromotor apraxia, and low scores on a nonword repetition task. Each of the two patients in the current report completed a 2-h assessment protocol that provided information on their cognitive, language, speech, oral mechanism, motor, and developmental histories and performance. Their histories and standard scores on perceptual and acoustic speech tasks met clinical and research criteria for CAS. Array comparative genomic hybridization analyses identified deletions at chromosome 16p11.2 in each patient. These are the first reported cases with well-characterized CAS in the 16p11.2 syndrome literature and the first report of this microdeletion in CAS genetics research. We discuss implications of findings for issues in both literatures.",
keywords = "aCGH, apraxia, dyspraxia, FOXP2, speech sound disorder",
author = "Gordana Raca and Baas, {Becky S.} and Salman Kirmani and Laffin, {Jennifer J.} and Jackson, {Craig A.} and Strand, {Edythe A.} and Jakielski, {Kathy J.} and Shriberg, {Lawrence D.}",
year = "2013",
month = "4",
doi = "10.1038/ejhg.2012.165",
language = "English (US)",
volume = "21",
pages = "455--459",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome

AU - Raca, Gordana

AU - Baas, Becky S.

AU - Kirmani, Salman

AU - Laffin, Jennifer J.

AU - Jackson, Craig A.

AU - Strand, Edythe A.

AU - Jakielski, Kathy J.

AU - Shriberg, Lawrence D.

PY - 2013/4

Y1 - 2013/4

N2 - We report clinical findings that extend the phenotype of the ∼550 kb 16p11.2 microdeletion syndrome to include a rare, severe, and persistent pediatric speech sound disorder termed Childhood Apraxia of Speech (CAS). CAS is the speech disorder identified in a multigenerational pedigree ('KE') in which half of the members have a mutation in FOXP2 that co-segregates with CAS, oromotor apraxia, and low scores on a nonword repetition task. Each of the two patients in the current report completed a 2-h assessment protocol that provided information on their cognitive, language, speech, oral mechanism, motor, and developmental histories and performance. Their histories and standard scores on perceptual and acoustic speech tasks met clinical and research criteria for CAS. Array comparative genomic hybridization analyses identified deletions at chromosome 16p11.2 in each patient. These are the first reported cases with well-characterized CAS in the 16p11.2 syndrome literature and the first report of this microdeletion in CAS genetics research. We discuss implications of findings for issues in both literatures.

AB - We report clinical findings that extend the phenotype of the ∼550 kb 16p11.2 microdeletion syndrome to include a rare, severe, and persistent pediatric speech sound disorder termed Childhood Apraxia of Speech (CAS). CAS is the speech disorder identified in a multigenerational pedigree ('KE') in which half of the members have a mutation in FOXP2 that co-segregates with CAS, oromotor apraxia, and low scores on a nonword repetition task. Each of the two patients in the current report completed a 2-h assessment protocol that provided information on their cognitive, language, speech, oral mechanism, motor, and developmental histories and performance. Their histories and standard scores on perceptual and acoustic speech tasks met clinical and research criteria for CAS. Array comparative genomic hybridization analyses identified deletions at chromosome 16p11.2 in each patient. These are the first reported cases with well-characterized CAS in the 16p11.2 syndrome literature and the first report of this microdeletion in CAS genetics research. We discuss implications of findings for issues in both literatures.

KW - aCGH

KW - apraxia

KW - dyspraxia

KW - FOXP2

KW - speech sound disorder

UR - http://www.scopus.com/inward/record.url?scp=84875055537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875055537&partnerID=8YFLogxK

U2 - 10.1038/ejhg.2012.165

DO - 10.1038/ejhg.2012.165

M3 - Article

C2 - 22909774

AN - SCOPUS:84875055537

VL - 21

SP - 455

EP - 459

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 4

ER -